טוען...
Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation
IL-18 is a crucial pro-inflammatory cytokine that mediates chronic intestinal inflammation. Metformin, an anti-diabetic drug, was reported to have ameliorative effects on inflammatory bowel disease. Recently, the mechanism of action of metformin was explained as a modulation of gut microbiota. In th...
שמור ב:
| הוצא לאור ב: | Immune Netw |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Association of Immunologists
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6722274/ https://ncbi.nlm.nih.gov/pubmed/31501716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2019.19.e28 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|